Short Interest in China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Decreases By 93.4%

China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) saw a large decline in short interest in March. As of March 15th, there was short interest totalling 5,500 shares, a decline of 93.4% from the February 29th total of 82,800 shares. Based on an average daily trading volume, of 1,040,000 shares, the days-to-cover ratio is currently 0.0 days. Currently, 1.0% of the shares of the stock are short sold.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Acadian Asset Management LLC raised its position in China SXT Pharmaceuticals by 130.8% during the first quarter. Acadian Asset Management LLC now owns 105,039 shares of the company’s stock valued at $28,000 after acquiring an additional 59,519 shares in the last quarter. Millennium Management LLC grew its stake in China SXT Pharmaceuticals by 48.1% in the 4th quarter. Millennium Management LLC now owns 67,648 shares of the company’s stock valued at $37,000 after buying an additional 21,963 shares during the last quarter. Virtu Financial LLC acquired a new position in China SXT Pharmaceuticals during the 4th quarter worth $48,000. Finally, Renaissance Technologies LLC increased its stake in shares of China SXT Pharmaceuticals by 2,009.8% in the first quarter. Renaissance Technologies LLC now owns 451,500 shares of the company’s stock worth $126,000 after purchasing an additional 430,100 shares during the period. 5.02% of the stock is currently owned by institutional investors and hedge funds.

China SXT Pharmaceuticals Trading Up 0.6 %

Shares of China SXT Pharmaceuticals stock traded up $0.01 on Thursday, hitting $1.69. The company had a trading volume of 24,820 shares, compared to its average volume of 591,606. China SXT Pharmaceuticals has a 52 week low of $1.56 and a 52 week high of $9.38. The business has a 50-day simple moving average of $1.90 and a 200-day simple moving average of $2.26.

China SXT Pharmaceuticals Company Profile

China SXT Pharmaceuticals, Inc, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.